Oncotelic and Sapu Nano Expand Phase 1b Trial of Sapu003
June 3, 2026 — Oncotelic Therapeutics and Sapu Nano expand Phase 1b trial of Sapu003 for advanced mTOR-sensitive solid tumors, appointing GCT as lead CRO for international study.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
LIXTE Biotechnology Raises $16.6M to Advance Cancer Therapies and Proton Therapy
June 3, 2026 — LIXTE Biotechnology Holdings announces $16.6M registered direct offering to strengthen balance sheet and advance cancer therapies including LB-100 and proton therapy. CEO Geordan Pursglove highlights growth phase.
TransCode’s TTX-MC138 Shows Durable Disease Stabilization in Phase 1a Trial
June 3, 2026 — TransCode Therapeutics reports Phase 1a results for TTX-MC138 showing durable disease stabilization in advanced cancer patients, supporting Phase 2a advancement. Learn more about RNAZ.
Biotech Giants Embrace Platform Models to Maximize Drug Delivery Value
June 3, 2026 — Biotech companies like Oncotelic Therapeutics are using nanotechnology and AI to improve drug delivery of existing cancer therapies, targeting a $410B market. Learn about the platform shift.
New Pill Doubles Survival in Pancreatic Cancer Trials
June 3, 2026 — A new pill, daraxonrasib, reportedly doubles survival in early pancreatic cancer trials. Revolution Medicines targets KRAS gene. Learn more at TinyGems.
Onco-Innovations Hits Key Manufacturing Milestone for Cancer Drug ONC010
June 3, 2026 — Onco-Innovations announces successful kilogram-scale manufacturing of B4 precursor for ONC010 cancer drug. Key milestone for clinical trials and scalable production. Learn more.
Biotech Platform Technologies: Oncotelic Leads AI-Driven Drug Delivery Revolution
June 3, 2026 — Biotech firms like Oncotelic leverage AI, nanotechnology, and platform tech to enhance therapies. Learn how Oncotelic's Sapu003 and PDAOAI programs are driving innovation in oncology and rare diseases.
Earth Science Tech: Healthcare Growth Meets Aggressive Share Buybacks
June 3, 2026 — Earth Science Tech (ETST) combines healthcare expansion with aggressive share repurchases, buying back 3.7M shares in nine months. Learn how this OTC company enhances shareholder value.
VolitionRx Files Patent for Nu.Q Ebola Triage Test
June 3, 2026 — VolitionRx files patent for Nu.Q Ebola triage test using nucleosome detection. Low-cost, rapid bedside solution for resource-constrained outbreak zones. Seeks partners for field trials.
Lexaria Bioscience Heads to BIO Convention to Boost Drug Delivery Partnerships
June 3, 2026 — Lexaria Bioscience attends BIO International Convention to expand business development for its DehydraTECH drug delivery platform, targeting partnerships with pharma giants.
Quantum BioPharma Targets Neurological and Wellness Markets with Diversified Pipeline
June 3, 2026 — Quantum BioPharma (QNTM) advances LUCID-MS for multiple sclerosis and unbuzzd(TM) for alcohol metabolism, targeting neurological and wellness markets as global neurological disease burden rises.
HHS Proposes Easing AI Health Care Regulations: What It Means
June 3, 2026 — HHS proposes easing AI health care regulations, affecting Alphabet Inc. and others. Debate between innovation and safety heats up. Read more on TrillionDollarClub.
GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms
June 3, 2026 — GeoVax CEO discusses Eli Lilly acquisitions highlighting renewed strategic interest in vaccine innovation, health security, and infectious disease resilience amid global biothreats like mpox and avian flu.
AHA Launches First-Ever Network to Revolutionize Heart Transplant Care
June 3, 2026 — American Heart Association launches first-ever heart transplant research network with 14 centers to transform care, address innovation gaps, and improve outcomes for patients.
Wellness Index Report: From Longevity to Root Cause Health
June 3, 2026 — The Wellness Index Report reveals a shift from longevity to root cause health, emphasizing personalized diagnostics, non-pharmaceutical pain management, and human connection for better quality of life.
Soil Health Key to Nutrient Density, ORGANA International Says
June 3, 2026 — ORGANA International highlights the soil-to-plate connection, emphasizing how soil health affects nutrient density in food. Learn about fulvic acid trace minerals and wellness products on Amazon.
Harvest Table Founders Share Clean-Label Collagen Vision in Citybiz Q&A
June 3, 2026 — The Harvest Table founders Catherine and Sam Clark discuss their clean-label collagen expansion into the U.S. market in a Citybiz Q&A, highlighting Amazon product launches and their health journey.
Smart Ways to Save Big on Dental Implants
June 3, 2026 — Learn how to save on dental implants without sacrificing quality. Affordable Dentist near Me – Mansfield shares smart strategies to find affordable dental implants and avoid low-quality deals.
Viromed's Cold Plasma Breakthrough in Lung Treatment
June 2, 2026 — Viromed Medical AG completes lung study on cold atmospheric plasma for VAP, showing complete germ reduction and clinical success in patients. A breakthrough in non-pharmacological intensive care.
Quantum BioPharma's Lucid-MS Targets MS Mobility Loss on BioMedWire Podcast
June 2, 2026 — Quantum BioPharma featured on BioMedWire Podcast discussing Lucid-MS for MS mobility loss and unbuzzd(TM) alcohol metabolism product. Phase 2 trial upcoming.